Buell Jennifer — SEC insider filings
SEC reporting owner CIK 1711184. 28 insider filings on record with FilingPulse; latest filed 2026-10-14.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2020-12-21 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 6,938 shares, $73,265 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 6,938 shares @ $10.56 ($73,265) in MiNK Therapeutics, Inc., filed 2026-10-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | Chief Executive Officer, Director | 11 | — | 1 leg · 6,938 sh · $73,265 | 20 |
| AGENUS INC (AGEN) | See Remarks, Director | 16 | — | — | 18 |
| Protagenic Therapeutics, Inc.\new (PTIX) | Director | 1 | — | — | 1 |
Insider filings — Buell Jennifer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-14 | 4 | MiNK Therapeutics, Inc. (INKT) | Option exercise (M): 23,191 · Sale (S): 6,938 @ $10.56 · Option exercise (M): 23,191 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | AGENUS INC (AGEN) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | AGENUS INC (AGEN) | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4/A | MiNK Therapeutics, Inc. (INKT) | Tax withholding (F): 10,024 @ $11.12 | EDGAR |
| 2026-01-06 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 31,474 @ $11.12 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4/A | MiNK Therapeutics, Inc. (INKT) | Tax withholding (F): 5,351 @ $15.36 | EDGAR |
| 2025-09-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 18,229 @ $15.36 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | AGENUS INC (AGEN) | Grant/award (A): 581 @ $3.11 | EDGAR |
| 2025-05-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 869 @ $2.08 | EDGAR |
| 2025-04-10 | 4 | AGENUS INC (AGEN) | Grant/award (A): 1,159 @ $1.56 | EDGAR |
| 2025-03-27 | 4 | AGENUS INC (AGEN) | Grant/award (A): 1,123 @ $1.61 | EDGAR |
| 2025-03-24 | 4 | AGENUS INC (AGEN) | Grant/award (A): 409 @ $2.35 | EDGAR |
| 2025-03-11 | 4 | AGENUS INC (AGEN) | Grant/award (A): 545 @ $3.32 | EDGAR |
| 2025-03-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 626 @ $3.32 | EDGAR |
| 2025-02-18 | 4 | AGENUS INC (AGEN) | Grant/award (A): 516 @ $3.50 | EDGAR |
| 2025-02-04 | 4 | AGENUS INC (AGEN) | Tax withholding (F): 270 @ $3.57 | EDGAR |
| 2025-01-28 | 4 | AGENUS INC (AGEN) | Grant/award (A): 776 @ $3.57 | EDGAR |
| 2024-11-18 | 4 | AGENUS INC (AGEN) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | Protagenic Therapeutics, Inc.\new (PTIX) | Grant/award (A): 75,000 (derivative) @ $1.74 | EDGAR |
| 2024-01-18 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 660,919 (derivative) @ $0 | EDGAR |
| 2023-10-13 | 4 | MiNK Therapeutics, Inc. (INKT) | Other (J): 695,750 · Grant/award (A): 695,750 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Tax withholding (F): 25,000 @ $1.15 · Tax withholding (F): 58,550 @ $1.04 · Tax withholding (F): 65,000 @ $0.94 | EDGAR |
| 2023-09-29 | 4 | MiNK Therapeutics, Inc. (INKT) | Option exercise (M): 695,750 · Option exercise (M): 695,750 (derivative) @ $0 | EDGAR |
| 2023-01-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 171,990 @ $2.32 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 679,800 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | AGENUS INC (AGEN) | Grant/award (A): 10,597 @ $5.49 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 80,838 @ $2.87 | EDGAR |
| 2020-12-21 | 4 | AGENUS INC (AGEN) | Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711184 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs